Craig W. Philips Takes Helm at CTI

President assumes day to day commercial and development responsibilities SEATTLE, Aug. 5 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (the "Company") (Nasdaq: CTIC; MTA) t announced that Craig W. Philips has assumed his role as CTI's new President, and will concentrate on managing the company's drug development and commercial operations. Most recently, Philips was Vice President and General Manager of Bayer Healthcare Oncology. He will report to CTI's James A. Bianco, M.D., who has served as President and Chief Executive Officer since its founding and will remain with the company as CEO. "Bringing Craig Philips on board at this time represents a milestone at CTI as the company has shifted from a research and development organization to a commercial operating company with the potential to expand the market indication for... [read full story]